NCT00306293 - VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 20, 2006

Primary Completion Date

November 27, 2006

Study Completion Date

November 27, 2006

Conditions

Herpes Labialis

Interventions

DRUG

valacyclovir

Trial Locations (18)

10029

GSK Investigational Site, New York

19140

GSK Investigational Site, Philadelphia

27103

GSK Investigational Site, Winston-Salem

27599

GSK Investigational Site, Chapel Hill

33437

GSK Investigational Site, Boynton Beach

33710

GSK Investigational Site, St. Petersburg

38104

GSK Investigational Site, Memphis

38120

GSK Investigational Site, Memphis

46202

GSK Investigational Site, Indianapolis

46601

GSK Investigational Site, South Bend

49024

GSK Investigational Site, Portage

74104

GSK Investigational Site, Tulsa

92123

GSK Investigational Site, San Diego

92805

GSK Investigational Site, Anaheim

95608

GSK Investigational Site, Carmichael

95628

GSK Investigational Site, Fair Oaks

95816

GSK Investigational Site, Sacramento

97210

GSK Investigational Site, Portland